Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

doctor examines patient data on their tablet

AVR for moderate AS: New 10-year data highlight clear benefits of TAVR, surgery

New research out of Cleveland Clinic explored long-term outcomes among patients with moderate aortic stenosis who were treated with TAVR, SAVR or clinical surveillance. TAVR and SAVR were both associated with clear improvements compared to surveillance alone. 

Medtronic’s MiniMed 780G automated insulin delivery system

Medtronic automated insulin pump named one of year’s ‘world-changing ideas’

The FDA-approved device includes meal detection technology that can deliver insulin when users lose track of time or underestimate how a meal may affect their health.

Women remain underrepresented in revascularization trials—can cardiology leaders reverse that trend?

“If together we do not just hope for, but demand, adequate representation as a necessary criterion for high-quality studies worthy of adoption into practice, we will have a real shot at achieving true equity in our trials," cardiologists said in a new commentary.

HRS president Jodie Hurwitz, MD, discusses trends in electrophysiology at the 2024 HRS meeting.

Exploring the biggest trends at HRS 2024

Heart Rhythm Society President Jodie Hurwitz, MD, told Cardiovascular Business that pulsed field ablation was one of the hottest topics at Heart Rhythm 2024. It may be early, she said, but the technology is already making an impact. 

Thumbnail

Keto diet linked to risk of significant heart damage—taking small breaks can help

Following a ketogenic diet for an extended period of time may age cells much faster than normal, according to new data published in Science Advances. This could be particularly damaging to the heart and kidneys.

WearLinq's eWave six-lead wearable ECG monitor

Wearable ECG specialists acquire new testing facility to reach more patients

San Francisco-based WearLinq says the acquisition will help its six-lead ECG technology reach more heart patients throughout the United States.   

The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse pulsed field ablation (PFA) system in patients with paroxysmal atrial fibrillation. #HRS #HRS2024 #PFA

Biosense Webster Varipulse PFA system performs well with minimal adverse events

"This was the first PFA IDE study to support a substantial number of fluoro-free procedures," said presenter Vivek Reddy, MD.

The EuroPCR 2024 meeting May 14-17 in Paris included four days of late-breaking interventional cardiology science presentations featured 12,100 participants, more than 550 educational sessions and 12 live cases. Photo courtesy of EuroPCR

5 takeaways from late-breaking studies at EuroPCR

The Society for Cardiovascular Angiography and Interventions offers its top five key takeaways from the EuroPCR 2024 meeting last week.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.